missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human CCL3L1/LD78 beta
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 509-MI-025
190.06 EUR valid until 2024-12-16
Use promo code "21630" to get your promotional price.
This item is not returnable.
View return policy
Description
The Recombinant Human CCL3L1/MIP-1 alpha Isoform LD78 beta is derived from E. coli. The Recombinant Human CCL3L1/MIP-1 alpha Isoform LD78 beta has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. | |
| 7.8 kDa | |
| 25μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |
| 6349 | |
| CCL3L1/MIP-1 alpha Isoform LD78 beta | |
| E. coli-derived human CCL3L1/MIP-1 alpha Isoform LD78 beta protein Ala24-Ala93 | |
| Unconjugated | |
| 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |